How AI Innovations Might Drive Up Healthcare Costs: An In-depth Analysis
November 26, 2025
Artificial intelligence (AI) shifts U.S. healthcare. AI touches care, tests, and drug
- April 22, 2026
Payer strategy, reimbursement, and market access
Artificial intelligence (AI) shifts U.S. healthcare. AI touches care, tests, and drug
Eli Lilly has cemented its place in pharmaceutical history by reaching an
Agios Pharmaceuticals recently faced a tumultuous period as its stock value took
Lundbeck’s surprise $2.4B counterbid rejected as Avadel board deems Alkermes’ CVR terms
Agios Pharmaceuticals recently faced a substantial decline in its stock value following
In a significant move that underscores the evolving landscape of cancer drug
Cogent Biosciences is making waves in the biopharmaceutical industry following the remarkable
Galapagos NV shuts down its cell therapy division, cuts 365 jobs, and
Roche’s investigational drug giredestrant is carving a niche for itself in the
In a significant move within the biopharmaceutical landscape, Novo Nordisk has secured
In a transformative move for the biotech industry, AstraZeneca has made headlines
The Trump administration’s unprecedented decision to implement layoffs at the Department of
The anticipation surrounding the Centers for Medicare and Medicaid Services (CMS) announcement
In a significant advancement for oncology, AstraZeneca and Daiichi Sankyo recently reported
